New combo therapy aims to slow liver cancer progression in tough cases
NCT ID NCT07187284
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 20 times
Summary
This study tests whether adding a procedure called endovascular denervation (EDN) to standard treatments (TACE/HAIC plus immune-targeted therapy) can help people with advanced liver cancer that has spread to the portal vein and has not responded to initial therapy. About 62 adults aged 18-75 will be randomly assigned to receive either the standard treatment alone or the standard treatment plus EDN. The goal is to see if the combination improves how long the cancer stays under control in the liver and to check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC - HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongda Hospital Affiliated to Southeast University, Department of Interventional and Vascular Surgery
Nanjing, Jiangsu, 210009, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.